“Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy”, FE, vol. 23, no. 1, Feb. 2022, doi: 10.7175/fe.v23i1.1516.